Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al.
作者信息
Gispen-de Wied Christine, de Boer Anthonius
机构信息
Medicines Evaluation Board, Utrecht, The Netherlands.
出版信息
Br J Clin Pharmacol. 2018 Aug;84(8):1639-1640. doi: 10.1111/bcp.13620. Epub 2018 May 31.
Abstract
摘要
相似文献
1
Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al.拉博茨等人所著《临床注册试验中的性别差异；是否存在真正的问题？》述评
Br J Clin Pharmacol. 2018 Aug;84(8):1639-1640. doi: 10.1111/bcp.13620. Epub 2018 May 31.
2
Gender Eligibility Descriptions for Clinical Trials.临床试验的性别合格标准说明。
JAMA. 2024 Apr 23;331(16):1415-1416. doi: 10.1001/jama.2024.0689.
3
Gender Eligibility Descriptions for Clinical Trials-Reply.临床试验的性别合格标准说明 - 回复
JAMA. 2024 Apr 23;331(16):1416-1417. doi: 10.1001/jama.2024.0692.
4
Characterizing Gender Eligibility Descriptions for Clinical Trials Registered on ClinicalTrials.gov.描述在ClinicalTrials.gov上注册的临床试验的性别合格标准
JAMA. 2023 Nov 28;330(20):2019-2021. doi: 10.1001/jama.2023.19517.
5
Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort.种族、性别、药物使用与参与艾滋病临床试验。来自一家市立医院队列研究的经验教训。
J Gen Intern Med. 1997 Mar;12(3):150-7. doi: 10.1007/s11606-006-5022-8.
6
Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
J Contemp Health Law Policy. 2000 Summer;16(2):305-54.
7
Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.慢性阻塞性肺疾病（COPD）真实世界患者纳入随机对照试验（RCTs）的资格：一篇评论
Respir Res. 2017 Jan 5;18(1):5. doi: 10.1186/s12931-016-0494-5.
8
Reevaluating Eligibility Criteria - Balancing Patient Protection and Participation in Oncology Trials.重新评估资格标准——平衡患者保护与参与肿瘤学试验
N Engl J Med. 2017 Apr 20;376(16):1504-1505. doi: 10.1056/NEJMp1615879.
9
Clinical trial participation after myocardial infarction in a national cardiovascular data registry.一项国家心血管数据登记处中心肌梗死后的临床试验参与情况
JAMA. 2014 Aug 27;312(8):841-3. doi: 10.1001/jama.2014.6217.
10
Semantic query generation from eligibility criteria in clinical trials.从临床试验的纳入标准生成语义查询。
AMIA Annu Symp Proc. 2007 Oct 11:1070.
引用本文的文献
1
Outcome differences by sex in oncology clinical trials.肿瘤学临床试验中性别导致的结果差异。
Nat Commun. 2024 Mar 23;15(1):2608. doi: 10.1038/s41467-024-46945-x.
2
The Next Frontier in Health Disparities-A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back.健康差异研究的下一个前沿——从实验室到临床再回到实验室，深入探讨神经胶质瘤数据和组学分析中的性别差异
Biomolecules. 2022 Aug 30;12(9):1203. doi: 10.3390/biom12091203.
3
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency.临床前和临床试验中的性别比例：对提交给欧洲药品管理局的22份上市许可申请档案的评估
Front Med (Lausanne). 2021 Mar 11;8:643028. doi: 10.3389/fmed.2021.643028. eCollection 2021.
本文引用的文献
1
Gender differences in clinical registration trials: is there a real problem?临床注册试验中的性别差异：这真的是个问题吗？
Br J Clin Pharmacol. 2018 Apr;84(4):700-707. doi: 10.1111/bcp.13497. Epub 2018 Feb 12.
2
Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis.急性躁狂症抗精神病药物治疗中的早期无反应：重新考虑治疗的标准？个体患者数据荟萃分析结果
J Clin Psychiatry. 2016 Sep;77(9):e1117-e1123. doi: 10.4088/JCP.15r10051.
3
Gender differences in coronary heart disease.冠心病的性别差异。
Neth Heart J. 2010 Dec;18(12):598-602. doi: 10.1007/s12471-010-0841-y.
Zotero 插件